Sarepta Therapeutics Inc (SRPT)

137.65 +1.12 (+0.82%)
Close USD Disclaimer
139.98 +2.33 (+1.69%)

SRPT Financial Summary

Sarepta Therapeutics, Inc. reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported revenue was USD 331.82 million compared to USD 230.27 million a year ago. Net loss was USD 40.94 million compared to USD 257.74 million a year ago. Basic loss per share from continuing operations was USD 0.46 compared to USD 2.94 a year ago. Diluted loss per share from continuing operations was USD 0.46 compared to USD 2.94 a year ago.For the nine months, revenue was USD 846.56 million compared to USD 674.59 million a year ago. Net loss was USD 581.63 million compared to USD 594.24 million a year ago. Basic loss per share from continuing operations was USD 6.56 compared to USD 6.79 a year ago. Diluted loss per share from continuing operations was USD 6.56 compared to USD 6.79 a year ago.
TTM
Trailing Twelve Months
MRQ
Most Recent Quarter
SRPT
Gross margin TTM 7.09%
Operating margin TTM -35.59%
Net Profit margin TTM -62.52%
Return on Investment TTM -16.15%
Total Revenue
Net Income
Title
Sep 30, 2023
Jun 30, 2023
Mar 31, 2023
Dec 31, 2022
Total Revenue 331.82 261.24 253.50 258.43
Gross Profit 100.49 -14.78 -27.20 19.82
Operating Income -20.84 -133.52 -138.09 -100.83
Net Income -40.94 -23.94 -516.76 -109.24
Clear All
0Selected
Please try another search
SRPT
Quick Ratio MRQ 4.63
Current Ratio MRQ 5.44
LT Debt to Equity MRQ 161.8%
Total Debt to Equity MRQ 181.78%
Total Assets
Total Liabilities
Title
Sep 30, 2023
Jun 30, 2023
Mar 31, 2023
Dec 31, 2022
Total Assets 3,109.71 3,125.89 3,059.79 3,128.37
Total Liabilities 2,345.35 2,384.48 2,347.04 2,743.42
Total Equity 764.36 741.41 712.75 384.95
Clear All
0Selected
Please try another search
SRPT
Cash Flow/Share TTM -5.78
Revenue/Share TTM 11.85
Operating Cash Flow -25.45%
Cash
Net Change in Cash
Title
Sep 30, 2023
Jun 30, 2023
Mar 31, 2023
Dec 31, 2022
Cash From Operating Activities -114.71 -122.23 -209.40 -92.39
Cash From Investing Activities -210.57 96.63 12.49 9.80
Cash From Financing Activities 15.40 5.86 101.80 10.75
Net Change in Cash -309.87 -19.74 -95.11 -71.85
Clear All
0Selected
Please try another search

* In Millions of USD (except for per share items)

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

Related Articles